Sponsored Content
Baxter
Pfizer's Agreement To Acquire Baxter’s Portfolio Of Marketed Vaccines Includes Facility in Austria
Pfizer Inc. announced that it has entered into a definitive agreement to acquire Baxter International Inc.’s portfolio of marketed vaccines for $635 million. As part of the transaction, Pfizer will also acquire a portion of Baxter’s facility in Orth, Austria, where these vaccines are manufactured.
August 1, 2014
Baxter Enlarges Viennese Site
The U.S. pharmaceutical group makes investments of € 30m in Vienna. The start of operation of a new production facility is planned in 2014.
May 18, 2012
Fast News Search
